Tshr-flox Mouse
一般名
Tshr-flox
製品ID
S-CKO-06467
背景情報
C57BL/6NCya
系統ID
CKOCMP-22095-Tshr-B6N-VA
状況
このマウス系統を論文で使用する場合は、「Tshr-flox Mouse(カタログ番号S-CKO-06467)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Tshr-flox
系統ID
CKOCMP-22095-Tshr-B6N-VA
遺伝子名
製品ID
S-CKO-06467
遺伝子別名
hyt, pet, hypothroid
遺伝子別名
C57BL/6NCya
NCBI ID
修正
Conditional knockout
染色体
Chr 12
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000021346
NCBIトランスクリプトID
NM_011648
ターゲット領域
Exon 10
有効領域の大きさ
~1.7 kb
遺伝子研究の概要
Tshr, the thyroid-stimulating hormone receptor gene, is crucial for thyroid function. It is a G-protein-coupled receptor that, upon binding thyroid-stimulating hormone (TSH), activates multiple signaling pathways such as the Gs/cyclic AMP and Gq/11 signaling pathways, which are essential for thyroid hormone synthesis and secretion. Post-translational modifications of Tshr, like glycosylation, phosphorylation, sialylation, and dimerization, modulate its cell-surface expression and signaling [5]. Tshr is also implicated in the regulation of immune-related processes, making it important in both normal physiological function and disease states.
In Graves' orbitopathy, Tshr is a key target antigen, and research on Tshr-inhibiting therapies is increasing, suggesting its potential as a therapeutic target [1]. In colorectal carcinoma, local TSH/Tshr signaling promotes CD8+ T-cell exhaustion and immune evasion. Conditional deletion of Tshr in CD8+ tumor-infiltrating lymphocytes (TILs) improved effector differentiation and suppressed the expression of immune checkpoint receptors through the protein kinase A (PKA)/cAMP-response element binding protein (CREB) signaling pathway [2]. The Tshr rs179247 gene polymorphism is associated with an increased risk of Graves' disease (GD) but not Hashimoto's thyroiditis (HT), indicating its potential as a biomarker for GD [3]. In congenital hypothyroidism, Tshr variants can lead to impairment of Gs/cyclic AMP and Gq/11 signaling activity, and patients with Tshr biallelic variants have a relatively mild clinical phenotype [4].
In summary, Tshr is essential for thyroid function and is involved in various disease-related processes. Research using gene-deletion models, such as the conditional deletion of Tshr in CD8+ TILs, has provided insights into its role in cancer-related immune evasion. In addition, studies on Tshr gene polymorphisms and variants have contributed to understanding its association with autoimmune thyroid diseases and congenital hypothyroidism, offering potential for disease prediction and treatment.
References:
1. Cui, Xuejiao, Wang, Futao, Liu, Cong. 2023. A review of TSHR- and IGF-1R-related pathogenesis and treatment of Graves' orbitopathy. In Frontiers in immunology, 14, 1062045. doi:10.3389/fimmu.2023.1062045. https://pubmed.ncbi.nlm.nih.gov/36742308/
2. Zeng, Sisi, Hu, Huiling, Li, Zhiyang, Wang, Zhizhang, Liang, Li. 2024. Local TSH/TSHR signaling promotes CD8+ T cell exhaustion and immune evasion in colorectal carcinoma. In Cancer communications (London, England), 44, 1287-1310. doi:10.1002/cac2.12605. https://pubmed.ncbi.nlm.nih.gov/39285586/
3. Zufry, Hendra, Hariyanto, Timotius Ivan. 2024. TSHR Gene (rs179247) Polymorphism and Susceptibility to Autoimmune Thyroid Disease: A Systematic Review and Meta-Analysis. In Endocrinology and metabolism (Seoul, Korea), 39, 603-614. doi:10.3803/EnM.2024.1987. https://pubmed.ncbi.nlm.nih.gov/39086275/
4. Zhang, Hai-Yang, Wu, Feng-Yao, Li, Xue-Song, Song, Huai-Dong, Zhao, Shuang-Xia. 2024. TSHR Variant Screening and Phenotype Analysis in 367 Chinese Patients With Congenital Hypothyroidism. In Annals of laboratory medicine, 44, 343-353. doi:10.3343/alm.2023.0337. https://pubmed.ncbi.nlm.nih.gov/38433572/
5. Kursawe, Romy, Paschke, Ralf. 2007. Modulation of TSHR signaling by posttranslational modifications. In Trends in endocrinology and metabolism: TEM, 18, 199-207. doi:. https://pubmed.ncbi.nlm.nih.gov/17524661/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
